OAKTREE CAPITAL MANAGEMENT LP

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 949509 LOS ANGELES, CA

Back to INDV Full portfolio

Position in INDV

as of Mar 31, 2026 · filed May 20, 2026 Compact

Position Value

$212,875,428

New position

Shares Held

6,984,102

first reported quarter

Ownership

5.73%

of shares outstanding

% of Portfolio

5.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

OAKTREE CAPITAL MANAGEMENT LP holds $214,021,949 across 3 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (99.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc. This page	6,984,102	$212,875,428
2	ALVO	Alvotech	240,038	$823,330
3	BTAI	BioXcel Therapeutics, Inc.	241,188	$323,191

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$212,875,428	6,984,102	—	Shares	Defined	2026-05-20
No filing history on record for this holder in this stock.

OAKTREE CAPITAL MANAGEMENT LP

Position in INDV

Position in Drug Manufacturers - Specialty & Generic

All Filings in INDV